Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCELA: HMR1766 in PAD
NCT00443287Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of ataciguat in intermittent claudication (IC), sponsored by Sanofi. Started Feb 2007; status: completed.
02
Drugs
ataciguat
03
Conditions
intermittent claudication (IC)
Beyond the preview
Go deeper on NCT00443287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443287.